Universal Vision Biotechnology Co., Ltd. 3218.TWO Stock
Universal Vision Biotechnology Co., Ltd. Price Chart
Universal Vision Biotechnology Co., Ltd. 3218.TWO Financial and Trading Overview
Contents
- Universal Vision Biotechnology Co., Ltd. Price Chart
- Universal Vision Biotechnology Co., Ltd. 3218.TWO Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Universal Vision Biotechnology Co., Ltd.
- Q&A For Universal Vision Biotechnology Co., Ltd. Stock
| Universal Vision Biotechnology Co., Ltd. stock price | 268 TWD |
| Previous Close | 398 TWD |
| Open | 398 TWD |
| Bid | 417.5 TWD x 0 |
| Ask | 418 TWD x 0 |
| Day's Range | 398 - 424 TWD |
| 52 Week Range | 229.5 - 458 TWD |
| Volume | 1.28M TWD |
| Avg. Volume | 663.98K TWD |
| Market Cap | 33.41B TWD |
| Beta (5Y Monthly) | 0.72226 |
| PE Ratio (TTM) | 37.32143 |
| EPS (TTM) | 12.32 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | April 21, 2022 |
| 1y Target Est | 385.67 TWD |
3218.TWO Valuation Measures
| Enterprise Value | 31.08B TWD |
| Trailing P/E | 37.32143 |
| Forward P/E | 30.4 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.562043 |
| Price/Book (mrq) | 12.543888 |
| Enterprise Value/Revenue | 8.895 |
| Enterprise Value/EBITDA | 24.005 |
Trading Information
Universal Vision Biotechnology Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.72226 |
| 52-Week Change | 55.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 458 TWD |
| 52 Week Low | 229.5 TWD |
| 50-Day Moving Average | 399.93 TWD |
| 200-Day Moving Average | 325.76 TWD |
3218.TWO Share Statistics
| Avg. Volume (3 month) | 663.98K TWD |
| Avg. Daily Volume (10-Days) | 521.4K TWD |
| Shares Outstanding | 79.93M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 47.50% |
| % Held by Institutions | 29.28% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 6 |
| Trailing Annual Dividend Yield | 1.50% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4225 |
| Last Split Factor | 1050:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 24.33% |
| Operating Margin (ttm) | 30.94% |
| Gross Margin | 61.24% |
| EBITDA Margin | 37.05% |
Management Effectiveness
| Return on Assets (ttm) | 16.40% |
| Return on Equity (ttm) | 33.66% |
Income Statement
| Revenue (ttm) | 3.49B TWD |
| Revenue Per Share (ttm) | 43.72 TWD |
| Quarterly Revenue Growth (yoy) | 29.89% |
| Gross Profit (ttm) | 2.14B TWD |
| EBITDA | 1.29B TWD |
| Net Income Avi to Common (ttm) | 850.39M TWD |
| Diluted EPS (ttm) | 11.2 |
| Quarterly Earnings Growth (yoy) | 32.39% |
Balance Sheet
| Total Cash (mrq) | 1.28B TWD |
| Total Cash Per Share (mrq) | 16.01 TWD |
| Total Debt (mrq) | 783.65M TWD |
| Total Debt/Equity (mrq) | 27.71 TWD |
| Current Ratio (mrq) | 2.372 |
| Book Value Per Share (mrq) | 33.323 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.27B TWD |
| Levered Free Cash Flow (ttm) | 574.26M TWD |
Profile of Universal Vision Biotechnology Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No.3-1 Yuanqu Street |
| ZIP | N/A |
| Phone | 886 2 2655 8000 |
| Website | https://www.eyecenter.com.tw |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Its clinics provide laser vision correction surgery for myopia, hyperopia, astigmatism, and presbyopia; intraocular lens surgery for presbyopia and cataract; phacoemulsification and femtosecond laser for cataract surgery; and myopia control services, as well as services for dry eyes, retinal detachment, macular degeneration, strabismus, amblyopia, and other eye diseases. The company also offers vision products and services, including a range of eyeglass frames, multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, regular/colored contact lenses, eye supplements, etc.; eye plastic and micro cosmetic surgery; and customized aesthetic medicine consulting. It operates 25 eye clinics and 34 optical stores in Taiwan; and 11 eye clinics and 11 optical stores in China. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.
Q&A For Universal Vision Biotechnology Co., Ltd. Stock
What is a current 3218.TWO stock price?
Universal Vision Biotechnology Co., Ltd. 3218.TWO stock price today per share is 268 TWD.
How to purchase Universal Vision Biotechnology Co., Ltd. stock?
You can buy 3218.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Universal Vision Biotechnology Co., Ltd.?
The stock symbol or ticker of Universal Vision Biotechnology Co., Ltd. is 3218.TWO.
Which industry does the Universal Vision Biotechnology Co., Ltd. company belong to?
The Universal Vision Biotechnology Co., Ltd. industry is Medical Devices.
How many shares does Universal Vision Biotechnology Co., Ltd. have in circulation?
The max supply of Universal Vision Biotechnology Co., Ltd. shares is 84.72M.
What is Universal Vision Biotechnology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Universal Vision Biotechnology Co., Ltd. PE Ratio is 21.75324800 now.
What was Universal Vision Biotechnology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Universal Vision Biotechnology Co., Ltd. EPS is 12.32 TWD over the trailing 12 months.
Which sector does the Universal Vision Biotechnology Co., Ltd. company belong to?
The Universal Vision Biotechnology Co., Ltd. sector is Healthcare.